Toggle navigation
Home
Search
Services
Blog
Contact
About
Human Monoclonal Antibodies
Hwang, Kou M.
Genelabs Technologies, Inc., Redwood City, CA, United States
Search 5 grants from Kou Hwang
Search grants from Genelabs Technologies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Discovery and optimization of novel mutant-selective allosteric inhibitors of EGFR T790M
International Differences in Health, Longevity, and SES
Neurobiological Study of the Reinforcing Efficacy of Cocaine in Unique Models
In Utero Transplantation in Beta-Thalassemic
Minority Predoctoral Fellowship Program
Recently added grants:
Epidemiology of Alcohol Problems: Alcohol-Related Disparities
Administration
National Alcohol Surveys: Advancing Epidemiologic Analyses of 21st Century Drinking
Health Disparities in Alcohol Use and Other Risk Behaviors after the Onset of Cancers and Cardiovascular Disease-Related Conditions
Quality of Alcohol-Related Care Received: Missed Opportunities, Disparities and Impacts of Health Reform
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067938-001
Application #
3614576
Study Section
Project Start
1986-09-18
Project End
Budget Start
1986-11-01
Budget End
1987-03-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Genelabs Technologies, Inc.
Department
Type
DUNS #
City
Redwood City
State
CA
Country
United States
Zip Code
94063
Related projects
NIH 1987
N43 CM
Human Monoclonal Antibodies
Hwang, Kou M. / Genelabs Technologies, Inc.
NIH 1986
N43 CM
Human Monoclonal Antibodies
Hwang, Kou M. / Genelabs Technologies, Inc.
Comments
Be the first to comment on this grant